Syncom Formulations India Ltd-$
Syncom Formulations Q2 FY27 Results Press Clipping
RESULTS
● No Immediate Change
LOW RISK
📅 Filed on BSE: 14 Nov 2026, 12:43 PM IST · BSE ID: f153526e-ee07-4808-92af-56b4508d69d4
View Original BSE Filing (PDF)
💡
In Simple Terms
The company published newspaper advertisements summarizing its financial results for the quarter and half year ending September 2026.
🤖 AI Summary
- Syncom Formulations submitted press clippings for Q2 FY27 and half year unaudited standalone and consolidated financial results.
- The financial results cover the quarter and half year ended September 30, 2026.
- Results were approved by the Audit Committee and Board of Directors on November 13, 2026.
- Advertisements were published on November 14, 2026, in Business Standard (English) and a Marathi newspaper.
- The advertisements include a QR code and weblink for access to complete financial results.
👥 What This Means For Shareholders
✅
Action Required
No direct action is required from shareholders based on this specific filing.
👤
Who Is Affected
All shareholders are informed that the company has completed the public dissemination of its Q2 FY27 financial results.
🔍
Management Signal
Management is demonstrating compliance with SEBI (LODR) Regulations, 2015, specifically Regulation 30 and 47(1), regarding financial result publication.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List - track these upcoming events
Review full Q2 FY27 standalone and consolidated financial results for detailed performance metrics.
Monitor future board meeting outcomes for any new strategic decisions or appointments.
Track next quarter's financial results for ongoing performance trends.
LOW RISK
This filing is procedural, indicating regulatory compliance rather than new risks.
💡 Investor Takeaway
Syncom Formulations India Ltd. completed the regulatory requirement of publishing extracts of its Q2 FY27 and half year standalone and consolidated financial results in newspapers on November 14, 2026, as approved by the Board on November 13, 2026. The full results are available online.
📅 Company Track Record
Previous filings on November 13, 2026, indicated Syncom Formulations' Q2 FY27 net profit increased 50.79% YoY to Rs. 2,539.55 Lakhs on a standalone basis.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What financial period do these press clippings for Syncom Formulations cover?
These press clippings cover the unaudited standalone and consolidated financial results for the Quarter and Half Year ended 30th September 2026 (Q2 FY27).
When were Syncom Formulations' financial results approved by the Board?
The financial results were considered and approved by the Audit Committee and Board of Directors at their respective meetings held on Friday, 13th November, 2026.
Where were the Syncom Formulations financial result advertisements published?
The advertisements were published on 14th November, 2026, in "Business Standard" Journal English Edition and a Marathi (vernacular) Newspaper.
How can investors access the complete financial results?
The advertisements contain a Quick Response (QR) code and a weblink providing access to the complete Unaudited Standalone and Consolidated Financial Results, which are also available on the company's website.
Questions based on this BSE filing only. For information purposes.